Global  

Moncef Slaoui

Moroccan-American-Belgian doctor and researcher

Moncef Slaoui    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Moncef Slaoui: Moroccan-American-Belgian doctor and researcher
Moncef Mohamed Slaoui is a Moroccan-born Belgian-American researcher and former head of GlaxoSmithKline's vaccines department. He worked at the company for thirty years, retiring in 2017. On May 15, 2020, President Donald Trump announced that Slaoui would manage the U.S. government's development of a vaccine used to treat coronavirus disease in Operation Warp Speed.

0
shares
ShareTweetSavePostSend
 

You Might Like


Deliver a safe, effective COVID-19 vaccine in less than a year? Impossible. Meet Moncef Slaoui.

As science adviser of Operation Warp Speed, the veteran pharmaceutical executive helped usher a coronavirus vaccine to the US market in record time.
USATODAY.com - Published

Operation Warp Speed vaccine development adviser discusses distribution plans

Even as the number of U.S. COVID-19 cases surpasses 12.5 million, there is some positive news. AstraZeneca is now the third pharmaceutical company with a promising vaccine candidate. Moncef Slaoui..
CBS News - Published

Covid: First Americans 'could get vaccine in December'

US vaccine chief Moncef Slaoui says the vaccination programme could begin as soon as 11 December.
BBC News - Published

Coronavirus Vaccine Could Bring U.S. Back to Normalcy By May

Light at the end of the tunnel!!! Maybe.  Because there's now a plan to vaccinate like crazy and get this country back to something that resembles normal by May, 2021. Dr. Moncef Slaoui, the chief..
TMZ.com - Published

Chief Vaccine Scientist Will Not Be Forced to Disclose Pharmaceutical Stocks

Dr. Moncef Slaoui, the chief adviser for the Trump administration’s coronavirus vaccine program, can remain a government contractor, thus shielding him from disclosure rules.
NYTimes.com - Published

Trump’s Vaccine Chief Has Vast Ties to Drug Industry, Posing Possible Conflicts

Moncef Slaoui, a former pharmaceutical executive, is now overseeing the U.S. initiative to development coronavirus treatments and vaccines. His financial interests and corporate roles have come under..
NYTimes.com - Published

Moncef Slaoui, ex-pharma exec tapped by Trump to lead vaccine group, will divest $10M stock options

The former pharmaceutical executive tapped last week to head Operation Warp Speed will divest $10 million in a company considered a front-runner.
USATODAY.com - Published

The ex-pharma exec leading Trump's COVID-19 vaccine program has $10 million in stock options for a company getting federal funding

the ex-pharma exec leading trump's covid-19 vaccine program has $10 million in stock options for a company getting federal funding
The former pharma executive tapped by President Donald Trump to lead the federal government's hunt for a COVID-19 vaccine has more than $10 million in stock options in one of the companies receiving..
WorldNews - Published

Coronavirus Vaccince Czar Says Finding One by January Is a 'Credible' Goal

Moncef Slaoui, a former pharmaceutical executive the White House chose to lead a crash development program, acknowledged that the 12-18 month timeline cited by Dr. Anthony Fauci was already “very..
NYTimes.com - Published

Former pharma exec tapped to head White House's 'Operation Warp Speed' coronavirus effort

President Trump on Wednesday tapped venture capitalist and former pharmaceutical head Moncef Slaoui to head coronavirus Operation Warp Speed.
USATODAY.com - Published